We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Antitrust Litigation Trends: Health Care

Law360 (February 14, 2007, 12:00 AM EST) -- Stung with accusations over a deal regarding its blood thinning medication Plavix, Bristol-Myers Squibb Co. was the health care company most embroiled in antitrust litigation in 2006, according to our survey of the 50 largest health care companies.

The antitrust litigations trends in 2006, as usual, followed the trail of regulators in 2006. Suits came as regulators probed both the Plavix deal and the five-biggest players in the orthopedic implant industry.

Meanwhile, reverse payments continue to be an issue after the U.S. Supreme Court refused in...
To view the full article, register now.